Welcome to our dedicated page for Mccormick & Co SEC filings (Ticker: MKC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The McCormick & Company, Incorporated Non-VTG CS (NYSE: MKC) SEC filings page brings together the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. McCormick, a global flavor manufacturer of herbs, spices, seasonings, condiments, and flavors, reports its financial condition, results of operations, and material events through forms such as the annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K.
Investors reviewing MKC filings can see how McCormick presents net sales, organic sales growth, gross profit, operating income, adjusted operating income, net income, and earnings per share, along with reconciliations of non-GAAP measures to GAAP results. The company also files 8-Ks to furnish earnings press releases, provide updates on its fiscal outlook, and disclose significant events. Examples include 8-K filings related to second and third quarter results and to the agreement and completion of the acquisition of an additional 25% ownership interest in McCormick de Mexico S.A. de C.V., a joint venture formed in 1947 with Grupo Herdez.
Through these filings, readers can track segment performance for the Consumer and Flavor Solutions businesses, as well as commentary on factors such as commodity costs, tariffs, foreign currency, and the impact of the Comprehensive Continuous Improvement (CCI) program. Current reports also describe transactions like the McCormick de Mexico ownership increase and reference associated press releases.
Stock Titan enhances access to these documents with AI-powered summaries that highlight key points from lengthy filings, including 10-K and 10-Q reports and 8-K disclosures. Real-time updates from EDGAR, combined with AI explanations, can help users quickly understand changes in McCormick’s reported results, outlook, and material events without manually parsing every page.
McCormick & Company is asking common stockholders to vote at its virtual 2026 annual meeting on April 1, 2026, with January 5, 2026 as the record date. Only voting common shares can vote, while non-voting common holders may attend and ask questions.
For 2025, net sales grew 2%, operating income rose 1% and adjusted operating income 2%. Earnings per share increased 0.3% and adjusted EPS 2%, supported by $962 million of operating cash flow. The company paid about $483 million in dividends, reaching $1.80 per share and marking 40 consecutive years of dividend increases. The board highlights a largely independent slate of 13 directors, pay-for-performance executive compensation tied to EPS, sales and long-term stock units, and extensive oversight of risk, sustainability, cybersecurity and human capital.
McCormick & Co. vice president and general counsel Jeffery D. Schwartz reported equity award activity involving restricted stock units and common shares. On February 15, 2026, 4,126 restricted stock units were exercised or converted, with no purchase price required, into an equivalent number of common shares.
To cover tax obligations on these and previously reported awards under McCormick's Long-Term Incentive Plan, 6,917 and 1,276 voting common shares were disposed of at $71.61 per share through tax-withholding transactions rather than open-market sales. After these movements, Schwartz directly held 87,241 voting common shares and 8,254 restricted stock units, plus 246 non-voting common shares. The restricted stock units vest in thirds over three years beginning on February 15, 2026, and were originally granted on February 7, 2025.
McCormick & Co. director Michael D. Mangan exercised 2,222 restricted stock units into voting common shares at no purchase price. The derivative transaction converted Restricted Stock Units into an equal number of Common Stock – Voting shares, reflecting an exercise or conversion of a derivative security.
Following the transaction on February 15, 2026, Mangan held 45,251 shares of Common Stock – Voting and 4,234 shares of Common Stock – Non Voting in direct ownership. The footnotes state that the restricted stock units required no purchase price and were granted on February 7, 2025, entitling him to receive an annual distribution of common stock equal to 100% of the grant.
McCormick & Co. director Margaret M. V. Preston reported exercising 2,222 Restricted Stock Units on February 15, 2026, converting them into 2,222 shares of Common Stock - Voting at $0.00 per share, reflecting equity compensation rather than an open-market purchase.
Following this derivative conversion, her directly held Common Stock - Voting position increased to 84,364.195 shares, and her directly held Common Stock - Non Voting holdings stood at 6,235.263 shares. The filing also shows her phantom stock balance under the Non Qualified Retirement Savings Plan at 0 shares, with phantom units payable in voting common shares under plan terms.
McCormick & Co. director Maritza Gomez Montiel reported the exercise of 2,222 Restricted Stock Units into an equal number of voting common shares on February 15, 2026. The RSUs required no purchase price and were originally granted on February 7, 2025.
Following this conversion, she directly holds 9,160 shares of voting common stock and 5,000 shares of non-voting common stock. The footnotes indicate the RSUs are subject to deferred receipt and entitle her to an annual distribution of common stock equal to 100% of the grant.
MCCORMICK & CO INC director Anne L. Bramman reported an equity award conversion. On February 15, 2026, she exercised 2,222 Restricted Stock Units at a price of $0.0000 per unit, converting them into 2,222 shares of Common Stock - Voting through a derivative exercise.
After this transaction, her directly held Common Stock position totaled 8,926.542 shares. The Restricted Stock Units require no purchase price, are subject to deferred receipt, and entitle her to receive an annual distribution of common stock equal to 100% of the grant, which was granted on February 7, 2025.
McCormick & Co. director Valarie L. Sheppard exercised Restricted Stock Units into common stock through a derivative conversion. She received 2,222 shares of voting common stock at a price of $0.00 per share, and now directly holds 2,570.47 shares after the transaction.
McCormick & Co. director Terry S. Thomas exercised restricted stock units into common shares. On February 15, 2026, 2,222 restricted stock units, which required no purchase price, were converted into 2,222 shares of voting common stock, bringing direct ownership to 3,966.01 shares.
The restricted stock units were granted on February 7, 2025 and entitle the holder to receive an annual distribution of common stock equal to 100% of the grant.
McCormick & Co Inc director Vernon W. Anthony exercised restricted stock units into common shares. On February 15, 2026, 2,222 Restricted Stock Units were converted with no purchase price, resulting in the acquisition of 2,222 shares of voting common stock.
Following this derivative exercise, Anthony directly holds 14,048 shares of McCormick voting common stock. The footnotes state the Restricted Stock Units required no purchase price and entitle him to receive an annual distribution of common stock equal to 100% of the grant, originally awarded on February 7, 2025.
McCormick & Co. director Gary M. Rodkin increased his direct holdings through an equity award vesting. On February 15, 2026, 2,222 Restricted Stock Units were exercised or converted with no purchase price required, reflecting an annual distribution of common stock equal to 100% of the grant.
The 2,222 Restricted Stock Units, originally granted on February 7, 2025, converted into 2,222 shares of McCormick voting common stock. Following this conversion, Rodkin directly owns 14,332 shares of McCormick common stock. No open-market purchases or sales were reported in this filing.